Dr. Ko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Walnut Street
10th Floor
Philadelphia, PA 19107Phone+1 215-829-2345
Summary
- Dr. Emily Ko is board certified in Gynecologic Oncology and Obstetrics and Gynecology, who currently serves as an Associate Professor at Hospital of the University of Pennsylvania and Pennsylvania Hospital, and Medical Director of the Pennsylvania Hospital Abramson Cancer Center. Located in Philadelphia, Dr. Ko has a subspecialty in Gynecologic Oncology. Her education includes a Residency at Harvard Medical School Brigham and Women's Hospital and Massachusetts General Hospital Combined OBGYN Residency, a medical degree from University of Massachusetts Medical School, a Fellowship in Gynecologic Oncology at University of North Carolina Hospitals, and an MSCR in Epidemiology from University of North Carolina Gillings School of Public Health. Dr. Ko's expertise spans surgical and medical management of all gynecologic cancers and pre-cancers as well as complex pelvic surgery. She is a prominent scholar in populations sciences and health services research as well as clinical trials with numerous publications in prestigious journals. She has conducted significant clinical trials and is well-respected in her field, as evidenced by her leadership roles in professional organizations and several honours and awards.
Education & Training
- University of North Carolina HospitalsFellowship, Gynecologic Oncology, 2012
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 2005 - 2009
- University of Massachusetts Medical SchoolClass of 2005
- University of North Carolina Gillings School of Public HealthMSCR, Epidemiology
Certifications & Licensure
- PA State Medical License 2013 - 2026
- NJ State Medical License 2017 - 2025
- NC State Medical License 2009 - 2013
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Candidate Member Society of Gynecologic Oncologists
- Member American Society of Clinical Oncologists
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Metformin for the Treatment of Endometrial Hyperplasia Start of enrollment: 2013 Jan 10
- Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer Start of enrollment: 2015 Jul 01
Publications & Presentations
PubMed
- Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer ...Paulina J Haight, Marilyn Sanchez, Samantha M Thomas, Carson Smitherman, Casey Cosgrove
Gynecologic Oncology. 2025-02-21 - Rideshare services for transportation assistance in gynecologic oncology: a quality improvement study.Anna Jo Smith, Sam Pancoe, Mary Pat Lynch, Megan Wachlin, Kristina Powell
BMC Health Services Research. 2025-02-14 - Impact of telehealth legislation on gynecologic oncology services: Policy updates.Elizabeth A Tubridy, Aaliyah Campbell, Lakeisha Mulugeta-Gordon, Leslie Andriani, Emily G Gleason
Gynecologic Oncology. 2025-02-13
Journal Articles
- Survival Following Minimally Invasive Radical Hysterectomy for Patients with Cervical Carcinoma and Tumor Size Less Than or Equal to 2 CmBenjamin Albright, Emily M Ko, American Journal of Obstetrics and Gynecology
- Trends in the Surgical Management of Malignant Ovarian Germ-Cell TumorsSpyridon A Mastroyannis, Emily M Ko, Gynecologic Oncology
Press Mentions
- Anti-Inflammatory Agents May Have Role in COVID-19 PneumoniaOctober 25th, 2022
- Blood Test Shows Promise in More Accurate Detection of Ovarian CancerJune 15th, 2022
- Gynecologic Cancer Survival Impacted by RaceMarch 15th, 2022
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Chinese (Mandarin), Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: